Literature DB >> 29725404

Exogenous hydrogen sulfide promotes hepatocellular carcinoma cell growth by activating the STAT3-COX-2 signaling pathway.

Yulan Zhen1, Qiaomei Wu2, Yiqian Ding3, Wei Zhang4, Yuansheng Zhai4, Xiaoxiong Lin4, Yunxia Weng4, Ruixian Guo5, Ying Zhang6, Jianqiang Feng5, Yiyan Lei7, Jingfu Chen8.   

Abstract

The effects of hydrogen sulfide (H2S) on cancer are controversial. Our group previously demonstrated that exogenous H2S promotes the development of cancer via amplifying the activation of the nuclear factor-κB signaling pathway in hepatocellular carcinoma (HCC) cells (PLC/PRF/5). The present study aimed to further investigate the hypothesis that exogenous H2S promotes PLC/PRF/5 cell proliferation and migration, and inhibits apoptosis by activating the signal transducer and activator of transcription 3 (STAT3)-cyclooxygenase-2 (COX-2) signaling pathway. PLC/PRF/5 cells were treated with 500 µmol/l NaHS (a donor of H2S) for 24 h. The expression levels of phosphorylated (p)-STAT3, STAT3, cleaved caspase-3 and COX-2 were measured by western blot assay. Cell viability was detected by Cell Counting kit-8 assay. Apoptotic cells were observed by Hoechst 33258 staining. The expression of STAT3 and COX-2 messenger RNA (mRNA) was detected by semiquantitative reverse transcription-polymerase chain reaction. The production of vascular endothelial growth factor (VEGF) was evaluated by ELISA. The results indicated that treatment of PLC/PRF/5 cells with 500 µmol/l NaHS for 24 h markedly increased the expression levels of p-STAT3 and STAT3 mRNA, leading to COX-2 and COX-2 mRNA overexpression, VEGF induction, decreased cleaved caspase-3 production, increased cell viability and migration, and decreased number of apoptotic cells. However, co-treatment of PLC/PRF/5 cells with 500 µmol/l NaHS and 30 µmol/l AG490 (an inhibitor of STAT3) or 20 µmol/l NS-398 (an inhibitor of COX-2) for 24 h significantly reverted the effects induced by NaHS. Furthermore, co-treatment of PLC/PRF/5 cells with 500 µmol/l NaHS and 30 µmol/l AG490 markedly decreased the NaHS-induced increase in the expression level of COX-2. By contrast, co-treatment of PLC/PRF/5 cells with 500 µmol/l NaHS and 20 µmol/l NS-398 inhibited the NaHS-induced increase in the expression level of p-STAT3. In conclusion, the findings of the present study provide evidence that the STAT3-COX-2 signaling pathway is involved in NaHS-induced cell proliferation, migration, angiogenesis and anti-apoptosis in PLC/PRF/5 cells, and suggest that the positive feedback between STAT3 and COX-2 may serve a crucial role in hepatocellular carcinoma carcinogenesis.

Entities:  

Keywords:  COX-2; PLC/PRF/5 cells; STAT3; growth; hydrogen sulfide

Year:  2018        PMID: 29725404      PMCID: PMC5920354          DOI: 10.3892/ol.2018.8154

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  50 in total

1.  Antitumor effects of celecoxib in COX-2 expressing and non-expressing canine melanoma cell lines.

Authors:  Kyoung-Won Seo; Ye-Rin Coh; Robert B Rebhun; Jin-Ok Ahn; Sei-Myung Han; Hee-Woo Lee; Hwa-Young Youn
Journal:  Res Vet Sci       Date:  2014-03-20       Impact factor: 2.534

2.  Hydrogen sulfide induces human colon cancer cell proliferation: role of Akt, ERK and p21.

Authors:  Wen-Jie Cai; Ming-Jie Wang; Li-Hua Ju; Cheng Wang; Yi-Chun Zhu
Journal:  Cell Biol Int       Date:  2010-04-14       Impact factor: 3.612

Review 3.  Hydrogen Sulfide and Cancer.

Authors:  Mark R Hellmich; Csaba Szabo
Journal:  Handb Exp Pharmacol       Date:  2015

Review 4.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; Josep M Llovet; Jordi Bruix
Journal:  Lancet       Date:  2012-02-20       Impact factor: 79.321

5.  The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008.

Authors:  C Verslype; E Van Cutsem; M Dicato; N Arber; J D Berlin; D Cunningham; A De Gramont; E Diaz-Rubio; M Ducreux; T Gruenberger; D Haller; K Haustermans; P Hoff; D Kerr; R Labianca; M Moore; B Nordlinger; A Ohtsu; P Rougier; W Scheithauer; H-J Schmoll; A Sobrero; J Tabernero; C van de Velde
Journal:  Ann Oncol       Date:  2009-06       Impact factor: 32.976

Review 6.  Endogenous production of hydrogen sulfide in mammals.

Authors:  P Kamoun
Journal:  Amino Acids       Date:  2004-04-08       Impact factor: 3.520

Review 7.  STATs in cancer inflammation and immunity: a leading role for STAT3.

Authors:  Hua Yu; Drew Pardoll; Richard Jove
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

8.  Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination.

Authors:  Xiaofeng Liang; Shengli Bi; Weizhong Yang; Longde Wang; Gang Cui; Fuqiang Cui; Yong Zhang; Jianhua Liu; Xiaohong Gong; Yuansheng Chen; Fuzhen Wang; Hui Zheng; Feng Wang; Jing Guo; Zhiyuan Jia; Jingchen Ma; Huaqing Wang; Huiming Luo; Li Li; Shuigao Jin; Stephen C Hadler; Yu Wang
Journal:  Vaccine       Date:  2009-09-01       Impact factor: 3.641

Review 9.  Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution.

Authors:  Bharat B Aggarwal; Gautam Sethi; Kwang Seok Ahn; Santosh K Sandur; Manoj K Pandey; Ajaikumar B Kunnumakkara; Bokyung Sung; Haruyo Ichikawa
Journal:  Ann N Y Acad Sci       Date:  2006-12       Impact factor: 5.691

10.  Rituximab-induced HMGB1 release is associated with inhibition of STAT3 activity in human diffuse large B-cell lymphoma.

Authors:  Tiansuo Zhao; He Ren; Xiuchao Wang; Pengfei Liu; Fan Yan; Wenna Jiang; Yang Li; Jing Li; John G Gribben; Li Jia; Jihui Hao
Journal:  Oncotarget       Date:  2015-09-29
View more
  4 in total

1.  Cystathionine β-synthase mediated PRRX2/IL-6/STAT3 inactivation suppresses Tregs infiltration and induces apoptosis to inhibit HCC carcinogenesis.

Authors:  Yu-Fu Zhou; Shu-Shu Song; Meng-Xin Tian; Zheng Tang; Han Wang; Yuan Fang; Wei-Feng Qu; Xi-Fei Jiang; Chen-Yang Tao; Run Huang; Pei-Yun Zhou; Shi-Guo Zhu; Jian Zhou; Jia Fan; Wei-Ren Liu; Ying-Hong Shi
Journal:  J Immunother Cancer       Date:  2021-08       Impact factor: 13.751

Review 2.  Hydrogen Sulfide Biology and Its Role in Cancer.

Authors:  Saadullah Khattak; Mohd Ahmar Rauf; Nazeer Hussain Khan; Qian-Qian Zhang; Hao-Jie Chen; Pir Muhammad; Mohammad Azam Ansari; Mohammad N Alomary; Muhammad Jahangir; Chun-Yang Zhang; Xin-Ying Ji; Dong-Dong Wu
Journal:  Molecules       Date:  2022-05-25       Impact factor: 4.927

Review 3.  Implications of hydrogen sulfide in liver pathophysiology: Mechanistic insights and therapeutic potential.

Authors:  Hai-Jian Sun; Zhi-Yuan Wu; Xiao-Wei Nie; Xin-Yu Wang; Jin-Song Bian
Journal:  J Adv Res       Date:  2020-05-17       Impact factor: 10.479

Review 4.  Role of hydrogen sulfide donors in cancer development and progression.

Authors:  Ebenezeri Erasto Ngowi; Attia Afzal; Muhammad Sarfraz; Saadullah Khattak; Shams Uz Zaman; Nazeer Hussain Khan; Tao Li; Qi-Ying Jiang; Xin Zhang; Shao-Feng Duan; Xin-Ying Ji; Dong-Dong Wu
Journal:  Int J Biol Sci       Date:  2021-01-01       Impact factor: 6.580

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.